Form 4: Sabra Health Care REIT Director Plans Stock Unit Acquisition
Insider Transaction Report
Sabra Health Care REIT Director Michael J. Foster reported a planned acquisition of 813 common stock units through dividend equivalent payments under a Rule 10b5-1(c) plan.
Summary
- Director Michael J. Foster reported a planned acquisition of 813 common stock units.
- This transaction is scheduled for August 29, 2025, and is made pursuant to a Rule 10b5-1(c) plan.
- The units represent dividend equivalent payments on previously granted stock units under the Issuer's 2009 Performance Incentive Plan.
- The acquisition price for these units is $0, as they are dividend equivalents.
- Following this planned transaction, Mr. Foster's direct beneficial ownership will be 73,130 shares of common stock.
- This direct ownership includes 6,922 unvested stock units and 45,688 vested but deferred stock units.
- Mr. Foster also indirectly owns 42,411.745 shares through a 401(k) Plan.
- These units will vest and become payable on the same terms as the original stock units to which they relate.
Sentiment
Score: 7
Explanation: The planned acquisition of additional stock units by a director, even through dividend equivalents and a pre-arranged plan, generally indicates continued alignment of interests and confidence in the company's long-term prospects. No negative information is presented in this routine filing.
Positives
- Director Michael J. Foster is set to increase his direct beneficial ownership by 813 common stock units through a pre-planned transaction.
- The acquisition of stock units via dividend equivalent payments indicates ongoing participation in the company's equity incentive plan and continued alignment with shareholder interests.
- The transaction is made under a Rule 10b5-1(c) plan, which demonstrates a pre-arranged, non-discretionary approach to insider transactions.
- The director's substantial total beneficial ownership (direct and indirect) reinforces confidence in the company.
Future Outlook
The filing itself does not contain forward-looking statements or guidance regarding the company's performance, but rather reports a pre-planned future insider transaction.
Industry Context
This is an insider transaction report, which primarily reflects an individual director's equity holdings and planned transactions. While not directly indicative of broader industry trends, director stock accumulation can be viewed as a sign of confidence in the healthcare REIT sector.
Stakeholder Impact
- Shareholders: Increased director ownership may be viewed as a positive signal of management's confidence in the company's future performance and alignment of interests.
Next Steps
- The acquired stock units will vest and become payable on the same terms as the original stock units to which they relate.
Key Dates
| Date | Description |
|---|---|
| 08/29/2025 | Date of earliest transaction for the planned acquisition of 813 common stock units. |
| 09/03/2025 | Signature date of the reporting person's attorney-in-fact for the Form 4 filing. |
Recommendation
holdThis Form 4 filing reports a routine, pre-planned acquisition of stock units by a director through dividend equivalent payments. While it demonstrates continued alignment of interests and confidence, it does not introduce new fundamental information about the company's financial performance or strategic direction that would warrant a change from a 'hold' position based solely on this filing. It is a positive, but not a significant catalyst.
Keywords
Sabra Health Care REIT, SBRA, Form 4, Insider Transaction, Director Stock Acquisition, Beneficial Ownership, Stock Units, Dividend Equivalents, Michael J. Foster, Rule 10b5-1(c)
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.